DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

A new focus on dermatology, ophthalmology, and gastroenterology will pave ways for many untapped opportunities that Viatris can utilize with its scale and manufacturing power. We believe Viatris is in ...

A comparative minnow, Torrent Pharmaceuticals, backed by a clutch of private equity players, also made a surprise bid but ...

Organon will also make additional payments of up to $950m on meeting commercial milestones, as well as tiered royalties on net product sales to Dermavant shareholders. Organon CEO Kevin Ali stated: ...

Key players in the adrenal crisis management are Eton Pharmaceuticals, Antares Pharma, Takeda Pharmaceutical Company Limited, Sandoz International GmbH, Pfizer Inc., Bristol-Myers Squibb Company, ...

Oct. 25, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”), a commercial-stage pharmaceutical company ... revenue is dependent mainly upon sales of our ...

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...

Read also: Natco Pharma partner Mylan settles patent litigation with Novo Nordisk over ... these future rivals to Novo will be able to secure the expertise to bring the product to market and have ...

The Federal Ministry of Health and Social Welfare is set to implement zero Value Added Tax and excise duties on pharmaceutical products and medical devices. A statement signed on Thursday by the ...